Reconciling IPRs and openness in biobanking

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Reconciling IPRs and openness in biobanking. / Verlinden, Michiel; Minssen, Timo; Huys, Isabelle .

In: European Intellectual Property Review, Vol. 38, No. 1 , 01.01.2016, p. 1-4.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Verlinden, M, Minssen, T & Huys, I 2016, 'Reconciling IPRs and openness in biobanking', European Intellectual Property Review, vol. 38, no. 1 , pp. 1-4.

APA

Verlinden, M., Minssen, T., & Huys, I. (2016). Reconciling IPRs and openness in biobanking. European Intellectual Property Review, 38(1 ), 1-4.

Vancouver

Verlinden M, Minssen T, Huys I. Reconciling IPRs and openness in biobanking. European Intellectual Property Review. 2016 Jan 1;38(1 ):1-4.

Author

Verlinden, Michiel ; Minssen, Timo ; Huys, Isabelle . / Reconciling IPRs and openness in biobanking. In: European Intellectual Property Review. 2016 ; Vol. 38, No. 1 . pp. 1-4.

Bibtex

@article{b456144c9adb4542ad6c5d0329d3279f,
title = "Reconciling IPRs and openness in biobanking",
abstract = "This opinion argues that carefully drafted IPR-policies could be used to protect the substantial investments made by biobanks in the collection of HBM and data while at the same time allowing scientists to share information and to seek IPRs on downstream inventions resulting from the use of such collections. We also recognize that the feasibility of IPR-policies depends on the specific types, set-ups and goals of biobanks and that some biobanks might have good reasons to refrain from being involved in IPRs. In many cases, however, an appropriate balance of the IPR-user modalities will be crucial to enhance translational medicine.",
keywords = "Faculty of Law, Open innovation, biobanking, ipr",
author = "Michiel Verlinden and Timo Minssen and Isabelle Huys",
year = "2016",
month = "1",
day = "1",
language = "English",
volume = "38",
pages = "1--4",
journal = "European Intellectual Property Review",
issn = "0142-0461",
publisher = "Sweet & Maxwell Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Reconciling IPRs and openness in biobanking

AU - Verlinden, Michiel

AU - Minssen, Timo

AU - Huys, Isabelle

PY - 2016/1/1

Y1 - 2016/1/1

N2 - This opinion argues that carefully drafted IPR-policies could be used to protect the substantial investments made by biobanks in the collection of HBM and data while at the same time allowing scientists to share information and to seek IPRs on downstream inventions resulting from the use of such collections. We also recognize that the feasibility of IPR-policies depends on the specific types, set-ups and goals of biobanks and that some biobanks might have good reasons to refrain from being involved in IPRs. In many cases, however, an appropriate balance of the IPR-user modalities will be crucial to enhance translational medicine.

AB - This opinion argues that carefully drafted IPR-policies could be used to protect the substantial investments made by biobanks in the collection of HBM and data while at the same time allowing scientists to share information and to seek IPRs on downstream inventions resulting from the use of such collections. We also recognize that the feasibility of IPR-policies depends on the specific types, set-ups and goals of biobanks and that some biobanks might have good reasons to refrain from being involved in IPRs. In many cases, however, an appropriate balance of the IPR-user modalities will be crucial to enhance translational medicine.

KW - Faculty of Law

KW - Open innovation, biobanking, ipr

M3 - Journal article

VL - 38

SP - 1

EP - 4

JO - European Intellectual Property Review

JF - European Intellectual Property Review

SN - 0142-0461

IS - 1

ER -

ID: 142220403